Analytic Investors’s Insys Therapeutics, Inc. INSY Stock Holding History

Analytic Investors’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-54,866	Closed	-$1.56M	–	705
2015 Q3	$1.56M	Sell	54,866 -46,854	-46%	-$1.72M	0.02%	314
2015 Q2	$3.65M	Buy	101,720 +9,242	+10%	+$288K	0.05%	203
2015 Q1	$2.69M	Sell	92,478 -7,750	-8%	-$205K	0.04%	228
2014 Q4	$2.11M	Buy	100,228 +29,714	+42%	+$588K	0.03%	243
2014 Q3	$1.37M	Sell	70,514 -27,064	-28%	-$425K	0.02%	318
2014 Q2	$1.52M	Sell	97,578 -16,566	-15%	-$268K	0.02%	274
2014 Q1	$2.36M	Buy	114,144 +96,645	+552%	+$1.92M	0.04%	260
2013 Q4	$226K	Buy	+17,499	New	+$243K	﹤0.01%	464

Other funds holding INSY

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Analytic Investors's INSY Position: Q4 2015 in Review

Analytic Investors sold out of Insys Therapeutics, Inc. (INSY) in Q4 2015, closing a stake of 54,866 shares — an estimated $1.56M sold.

Analytic Investors first reported a position in INSY in Q4 2013 and held it in 8 quarters. The position peaked at $3.65M in Q2 2015. 154 funds tracked by Wall St. Rank hold INSY as of Q4 2015.

Analytic Investors reported no remaining Insys Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
Analytic Investors sold 54,866 Insys Therapeutics, Inc. shares in Q4 2015, an estimated $1.56M.
Analytic Investors first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 8 quarters.
Analytic Investors's Insys Therapeutics, Inc. position peaked at $3.65M in Q2 2015.
154 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2015.

Based on Analytic Investors's 13F filing for Q4 2015, filed 12 Feb 2016.